1. Home
  2. /
  3. High-risk tips & news
  4. /
  5. Telemedicine and online pharmacy...

Telemedicine and online pharmacy payment gateway news – updated 11/17/2026 –

If you run a telehealth practice or an online pharmacy, a merchant account that works fine today can be on hold tomorrow. Often all it takes is a new DEA deadline, an FDA compounding decision, or a change in Visa or Mastercard rules.

We track those changes here. Each dated entry below covers one piece of news for telehealth practices and the pharmacies that compound, ship by mail, or fill prescriptions for them, plus what we expect it to mean for payment gateways and merchant accounts.

Please look into any service carefully before you choose one, and get qualified legal advice before you launch a practice or pharmacy, or change how it sells online.

* We are not attorneys, and nothing on this page should be taken as legal advice.

Helping high-risk merchants find the best, most stable way to process credit cards long-term is what Tasker Payment Gateways LLC has done since 2002, and the BBB rates us A+ as an accredited business. If your telehealth practice or online pharmacy can’t get approved, or its account was frozen after a rule change, we can probably help.

Experience matters

Each of our dedicated independent agents has at least 10 years of experience in the industry and has personally helped a minimum of 500 regulated business owners accept credit cards.

Have a question about a payment gateway or merchant account for your practice or pharmacy? Contact us for free, friendly advice.

11/17/2026 – HHS peptide policy and a LegitScript change may help more online pharmacies get merchant accounts

On October 30, 2026, the US Department of Health and Human Services (HHS) said in the Federal Register that it does not intend to take enforcement action against state-licensed pharmacies and physicians that compound six peptides under section 503A: BPC-157, TB-500, Epitalon, KPV, MOTS-c, and Semax. The policy only applies when all 10 of its conditions are met, including FDA-registered sourcing and a patient-specific prescription.

This is not FDA approval, it doesn’t add the peptides to the 503A bulks list, and it doesn’t cover 503B outsourcing facilities. HHS calls it an interim policy and says it may revisit it if a safety or product quality problem comes up.

One odd note: the policy came from the HHS Secretary’s office, not the FDA, which administers 503A compounding, and according to Holland & Knight, FDA’s own drug reviewers had recommended against listing these peptides. That’s one more reason to expect the policy could change.

LegitScript says the six peptides shouldn’t block certification on their own

On November 2, 2026, LegitScript updated its certification review to say that offering one of these six peptides should not, by itself, prevent certification, as long as the offering meets the HHS policy’s conditions and LegitScript’s other standards. Peptides and formulations that fall outside the policy are still a barrier.

In our experience, either LegitScript certification or an industry-accepted alternative is required to get an online pharmacy merchant account, so this change may help pharmacies that offer these peptides. LegitScript itself points out that payment processors set their own rules, though, and some may not want peptides at all. If you offer them, we expect underwriters to ask which peptides you sell and which pharmacy compounds them, and to want copies of the certificates of analysis.

Please have a qualified attorney review your peptide offering, labels, and marketing before you launch.

Need an online pharmacy or telehealth payment gateway or merchant account recommendation? Contact us any time for free, friendly advice.

Sources:

Federal Register – https://www.federalregister.gov/documents/2026/10/30/2026-22192/enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances

LegitScript – https://www.legitscript.com/healthcare/hhs-peptide-compounding-policy-what-healthcare-businesses-need-to-know/

Holland & Knight – https://www.hklaw.com/en/insights/publications/2026/11/hhs-issues-interim-enforcement-discretion-policy-for-compounding